Zobrazeno 1 - 10
of 62
pro vyhledávání: '"AM Brunt"'
Autor:
P Schmid, M Zaiss, C Harper-Wynne, M Ferreira, S Dubey, S Chan, A Makris, G Nemsadze, AM Brunt, S Kuemmel, I Ruiz Cabrero, A Perelló, A Kendall, J Brown, H Kristeleit, J Conibear, C Saura, J Grenier, K Máhr, M Schenker, JH Sohn, KS Lee, S-J Sarker, C Coetzee, K Mousa, J Cortes Castan
Publikováno v:
Cancer Research. 78:GS2-07
Background: Resistance to endocrine therapy remains a major clinical challenge with aberrant PI3K/ mTOR pathway activation being one of the main drivers. Randomised clinical trials have demonstrated a substantial benefit of adding everolimus to endoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c05c2dab8212444d85364bd059f039d6
https://doi.org/10.1158/1538-7445.sabcs17-gs2-07
https://doi.org/10.1158/1538-7445.sabcs17-gs2-07
Publikováno v:
Acta Dermato Venereologica. 91:440-443
The incidence of melanoma in the North Staffordshire region has more than doubled over the last 10 years, and nearly tripled in the "thin" melanoma group (≤ 1 mm). A retrospective audit was performed to investigate the overall management of melanom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed4d66766ba687e36e2f57155c3ead43
https://doi.org/10.2340/00015555-1069
https://doi.org/10.2340/00015555-1069
Publikováno v:
Europe PubMed Central
A consecutive series of 411 patients with primary breast cancer treated by a consistent policy of breast conservation, regardless of tumour size, location, clinical stage or histological subtype, is reported. Actuarial 5-year survival was 84% for UIC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6cff0b842f296f20c193fee8e145417b
https://pubmed.ncbi.nlm.nih.gov/2604349
https://pubmed.ncbi.nlm.nih.gov/2604349
Publikováno v:
Europe PubMed Central
The indications, technique and complications of salvage mastectomy in 25 patients with local recurrence after breast-conserving therapy for carcinoma of the breast have been reviewed. Two patients required myocutaneous flaps to repair the defect, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5d6feb59ae9d2d3cebbd668938e6853a
http://europepmc.org/abstract/med/2018316
http://europepmc.org/abstract/med/2018316
Autor:
Velikova G; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds Cancer Centre, St James's University Hospital, Leeds, UK. Electronic address: g.velikova@leeds.ac.uk., Morden JP; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds Cancer Centre, St James's University Hospital, Leeds, UK., Haviland JS; Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Emery C; Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Barrett-Lee P; Department of Oncology, Velindre University NHS Trust, Cardiff, UK., Earl H; Department of Oncology, University of Cambridge, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Bloomfield D; Department of Oncology, University Hospitals Sussex, Brighton, UK., Brunt AM; School of Medicine, University of Keele, Keele, UK; Department of Oncology, University Hospitals of North Midlands, Stoke-on-Trent, UK., Canney P; Beatson Oncology Center, Glasgow, UK., Coleman R; Department of Oncology, Weston Park Hospital, Sheffield, UK., Verrill M; Department of Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Wardley A; Outreach Research and Innovation Group, Manchester, UK., Bertelli G; Department of Oncology, University Hospitals Sussex, Brighton, UK., Ellis P; King's College London and Leaders in Oncology Care, London, UK., Stein R; University College London Hospitals, London, UK., Bliss JM; Institute of Cancer Research Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Cameron D; University of Edinburgh Cancer Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Dec; Vol. 24 (12), pp. 1359-1374. Date of Electronic Publication: 2023 Nov 02.
Autor:
Brunt AM; School of Medicine, University of Keele and University Hospitals of North Midlands, Staffordshire, UK.; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Haviland JS; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Wheatley DA; Department of Oncology, Royal Cornwall Hospital NHS Trust, Truro, UK., Sydenham MA; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Bloomfield DJ; Sussex Cancer Centre, Brighton and Sussex University Hospitals, Brighton, UK., Chan C; Women's Health Clinic, Nuffield Health Cheltenham Hospital, Cheltenham, UK., Cleator S; Department of Oncology, Imperial Healthcare NHS Trust, London, UK., Coles CE; Department of Oncology, University of Cambridge, Cambridge, UK., Donovan E; Centre for Vision, Speech and Signal Processing, University of Surrey, Guildford, UK., Fleming H; Clinical and Translational Radiotherapy Research Group, National Cancer Research Institute, London, UK., Glynn D; Centre for Health Economics, University of York, York, UK., Goodman A; Oncology Unit, Torbay Hospital, Devon, UK., Griffin S; Centre for Health Economics, University of York, York, UK., Hopwood P; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Kirby AM; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, UK and Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kirwan CC; Division of Cancer Sciences, University of Manchester, Manchester, UK., Nabi Z; RTQQA, Mount Vernon Cancer Centre, Middlesex, UK., Patel J; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Sawyer E; Comprehensive Cancer Centre, King's College London, London, UK., Somaiah N; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, UK and Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Syndikus I; Clatterbridge Cancer Centre, Clatterbridge Hospital NHS Trust, Cheshire, UK., Venables K; RTQQA, Mount Vernon Cancer Centre, Middlesex, UK., Yarnold JR; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, UK and Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Bliss JM; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.
Publikováno v:
Health technology assessment (Winchester, England) [Health Technol Assess] 2023 Nov; Vol. 27 (25), pp. 1-176.
Autor:
Coles CE; Department of Oncology, University of Cambridge, Cambridge, UK. Electronic address: cec50@cam.ac.uk., Haviland JS; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Kirby AM; Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK., Griffin CL; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Sydenham MA; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Titley JC; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Bhattacharya I; Department of Oncology and Radiotherapy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Brunt AM; School of Medicine, University of Keele, Keele, UK; University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK., Chan HYC; Department of Breast Surgery, Nuffield Health Cheltenham Hospital, Cheltenham, UK., Donovan EM; Centre for Vision, Speech and Signal Processing, University of Surrey, Guildford, UK., Eaton DJ; Department of Medical Physics, Guy's and St Thomas' Hospitals, London, UK., Emson M; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Hopwood P; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK., Jefford ML; Independent Cancer Patients Voice, London, UK., Lightowlers SV; Department of Oncology, University of Cambridge, Cambridge, UK., Sawyer EJ; Guy Cancer Centre School of Cancer and Pharmaceutical Sciences, Guy's and St Thomas' Foundation Trust, Kings College London, London, UK., Syndikus I; Department of Radiotherapy, Clatterbridge Cancer Centre, Bebington, UK., Tsang YM; Radiotherapy Trials QA Group, Mount Vernon Cancer Centre, Northwood, UK., Twyman NI; Department of Medical Physics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Yarnold JR; Department of Radiotherapy and Imaging, Institute of Cancer Research, Sutton, UK., Bliss JM; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Jun 24; Vol. 401 (10394), pp. 2124-2137. Date of Electronic Publication: 2023 Jun 08.
Autor:
Fernando IN; Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK. Electronic address: indrajit.fernando@uhb.nhs.uk., Lax S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Bowden SJ; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Ahmed I; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Steven JH; Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK., Churn M; Clinical Oncology, Worcestershire Royal Hospital, Worcester, UK., Brunt AM; Cancer Centre, Royal Stoke University Hospital, Stoke on Trent, UK; Keele University, Keele, UK., Agrawal RK; The Shrewsbury and Telford NHS Trust, Shrewsbury, UK., Canney P; Beatson West of Scotland Cancer Centre, Glasgow, UK., Stevens A; Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK., Rea DW; Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Jun; Vol. 35 (6), pp. 397-407. Date of Electronic Publication: 2023 Mar 20.